Levozal

Levozal

levocetirizine

Manufacturer:

Idaman Pharma

Distributor:

Pharmaniaga Logistics
Concise Prescribing Info
Contents
Levocetirizine diHCl
Indications/Uses
Symptomatic treatment of allergic rhinitis including persistent allergic rhinitis & chronic idiopathic urticaria.
Dosage/Direction for Use
Adult, adolescent ≥12 yr, childn 6-12 yr & mild renal impairment (CrCl 50-79 mL/min) 5 mg once daily. Moderate renal impairment (CrCl 30-49 mL/min) 5 mg once daily once every 2 days, severe renal impairment (CrCl <30 mL/min) 5 mg once daily once every 3 days.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to levocetirizine, cetirizine, hydroxyzine or any piperazine derivatives. Galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. Severe renal impairment (CrCl <10 mL/min).
Special Precautions
Predisposing factors of urinary retention eg, spinal cord lesion, prostatic hyperplasia; patients w/ epilepsy or at risk of convulsion. Consider 3-day wash-out period before performing allergy skin tests. Avoid alcohol consumption. W/drawal syndrome. Not to be taken by patients w/ galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. May affect ability to drive & use machines. Renal & hepatic impairment. Pregnancy & lactation. Elderly.
Adverse Reactions
Headache, somnolence; dry mouth; fatigue.
Drug Interactions
Small decreased clearance w/ theophylline. Increased exposure w/ ritonavir. Decreased absorption rate w/ food. Reduced alertness & impaired performance w/ alcohol or other CNS depressants.
MIMS Class
Antihistamines & Antiallergics
ATC Classification
R06AE09 - levocetirizine ; Belongs to the class of piperazine derivatives used as systemic antihistamines.
Presentation/Packing
Form
Levozal FC tab 5 mg
Packing/Price
10 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in